Transforming nursing assessment in acute hospitals: A cluster randomised controlled trial of Evidence-based Nursing CORE assessment (the ENCORE trial)
- Conditions
- Deteriorating patients in general wardsPublic Health - Health service research
- Registration Number
- ACTRN12618001903279
- Lead Sponsor
- Queensland University of Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 36000
Clusters: Eligible hospital wards (clusters) will be general acute care wards, between 20-30 beds and where >70% of nursing staff are permanent (full or part time).
Patients: Patients will be recruited prospectively from all hospitals using identical tools and methods, six months following commencement of the intervention allowing embedding of the intervention into routine care. All eligible patients admitted to participating wards over a six month period will be recruited using an opt-out approach for access to medical records. Eligible patients will be 18 years and over and screened by ward nursing staff as able to read and understand the plain language study information provided on admission.
Nursing and Medical Staff: All nurses who work as permanent staff in the participating wards and medical officers in those wards will be invited to participate in a survey at baseline, 6 months and 12 months post intervention.
Specialist acute care units (e.g., ICU, Coronary Care Unit, Operating Theatres) will be ineligible to participate.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Medical emergency team (MET) activations collected from patient records. These data will be cross-checked and validated by comparison with MET data by ward.[6 months after intervention commencement.]
- Secondary Outcome Measures
Name Time Method ursing and medical staff perceptions of safety culture will be measured using the short form Safety Attitudes Questionnaire (SAQ). [6 months after intervention commencement.];Economic evaluation: a benefit-to-cost ratio for the ENCORE intervention related to MET activations, ICU admissions and average patient length of stay. Resource use will be identified through trial records (i.e. for the intervention) and through linkage to admitted patient data in each participating state.[6 months after intervention commencement.];Serious adverse events defined as a composite of unplanned intensive care unit (ICU) admissions, on-ward resuscitations, and unexpected deaths. Collected from the patient records.[6 months after intervention commencement.]